title: Beta adrenergic receptors in human cavernous tissue.
abstract: Beta adrenergic receptor binding was performed with 125I iodocyanopindolol on human cavernous tissue membrane fractions from normal tissue and transsexual procedures obtained postoperatively, as well as from postmortem sources. Isotherm binding studies on normal fresh tissues indicated that the receptor density was 9.1 fmoles/mg. with a KD of 23 pM. Tissue stored at room temperature for 4 to 6 hours, then at 4C in saline solution for 19 to 20 hours before freezing showed no significant changes in receptor density or affinity, and provided evidence for the stability of postmortem tissue obtained within the same time period. Beta receptor density of 2 cavernous preparations from transsexual procedures was not significantly different from normal control tissues, and showed that high concentrations of estrogen received by these patients had no effect on beta adrenergic receptor density. Displacement of 125iodocyanopindolol by 5 beta adrenergic agents demonstrated that 1-propranolol had the greatest affinity followed by ICI 118,551, zinterol, metoprolol and practolol. When the results of these displacement studies were subjected to Scatfit, non-linear regression line analysis, a single binding site was described. Based on the relative potency of the selective beta adrenergic agents it appears that these receptors were of the beta 2 subtype.
authors.forename: C B
authors.initials: CB
authors.lastname: Dhabuwala
authors.forename: C V
authors.initials: CV
authors.lastname: Ramakrishna
authors.forename: G F
authors.initials: GF
authors.lastname: Anderson
mesh_terms: D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D001665:Binding Sites; D004983:Ethanolamines / Q000494:pharmacology; D006801:Humans; D007457:Iodine Radioisotopes; D020120:Iodocyanopindolol; D008297:Male; D008790:Metoprolol / Q000494:pharmacology; D010413:Penis / Q000294:innervation*; D010869:Pindolol / Q000031:analogs & derivatives; D011217:Practolol / Q000494:pharmacology; D011412:Propanolamines / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011943:Receptors, Adrenergic, beta / Q000032:analysis* / Q000187:drug effects / Q000378:metabolism
chemical_list: D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D004983:Ethanolamines; D007457:Iodine Radioisotopes; D011412:Propanolamines; D011943:Receptors, Adrenergic, beta; C026777:ICI 118551; C002904:zinterol; D020120:Iodocyanopindolol; D011433:Propranolol; D010869:Pindolol; D008790:Metoprolol; D011217:Practolol